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Reply
There is legitimate concern about the placement of a covered
stent to treat a pseudoaneurysm that has occurred within an
arteriovenous malformation. In this particular case, the stent graft
covered three large feeders to the arteriovenous malformation
(Fig). This certainly will preclude access through these particular
branches if embolization were to be required in the future to treat
the arteriovenous malformation. The malformation, however, has
other feeders distal to the endograft and directly from the vertebral
artery. These remain accessible for future treatment. In addition,
direct intralesional injection will also be an option.
The issue on presentation was an expanding pseudoaneurysm
within a large arteriovenous malformation, which could not be
addressed with surgical resection and/or repair. We contemplated
embolization of the arteriovenous malformation before endograft
deployment, however, two of the feeders to the malformation
came off of the pseudoaneurysm. In addition, before the trauma
Fig. Pretreatment angiogram of traumatic pseudoaneurysm
within a congenital arteriovenous malformation.that led to the pseudoaneurysm, the arteriovenous malformation
had been stable. The patient is now more than 3 years after
endograft placement with significant decrease in the size of the
pseudoaneurysm and a stable arteriovenous malformation.
I appreciate bringing this issue to our and the attention of the
readers. It is an important consideration in the management of
these very complex lesions.
William J. Quinones-Baldrich, MD
Professor of Surgery
UCLA Medical Center
Los Angeles, Calif
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Regarding “Peripheral arterial interventions: Trends
in market share and outcomes by specialty, 1998-2005”
The article by Eslami et al1 describes not only the shift of
market share of endovascular procedures over time from interven-
tional radiology (IR) to vascular surgery (VS) and interventional
cardiology (IC) but also purports to show a significant difference in
hospital mortality and iatrogenic vascular injuries. There are some
systemic weaknesses in the data and analysis.
First, as the authors acknowledge, the data sampled is limited
to inpatients—a tiny minority of peripheral arterial disease patients.
The accompanying commentary by Sataini describes this as only
3% of interventional procedures actually performed in this country,
an estimate confirmed by Levin et al.2 Outpatients are more likely
to be healthier and have a lower complication rate. If one specialty
were more likely than another to perform outpatient procedures,
this would skew the data for both market share and complication
rate. Including outpatient data for the year 2002, Levin et al,2
reported the market shares for IR, VS, and IC were, respectively,
42%, 10%, and 36%. For the same year, Eslami et al report market
shares for IR, VS, and IC of 25%, 25%, and 27%. This supports the
contention that analyzing only inpatients underestimates IR mar-
ket share and likely overestimates IR complications.
Second, patients with lower extremity arteriography were in-
cluded for analysis. Diagnostic arteriography is less likely to lead to a
complication than a procedure that includes both the diagnostic
arteriogram and intervention. If one specialty is more likely than
another to perform a revascularization procedure as a separate proce-
dure from the diagnostic arteriogram, that specialty will be recorded
as having more total procedures and a lower overall complication rate.
Eslami et al state that for IC, only 5% of interventions are performed at
the same time as the diagnostic arteriogram. In my experience for IR,
90% of interventions are performed at the same time, and my
hospital uses the 90% benchmark as a quality threshold for all special-
ties. This large difference suggests that the analysis underestimates IR
market share and overestimates IR complications.
Third, it is possible there was systemic under-reporting of iatro-
genic arterial injuries by vascular surgeons. For example, a coder may
not note a complication if a surgeon converted a percutaneous to an
open femoral access due to problems with the access.
Fourth, identification of physician specialty is not accurate. IR
physicians are identified as providers who not only perform peripheral
arterial interventions but also either transjugular intrahepatic porto-
systemic shunt or nephrostomy, but not aortic stent grafting (endo-
vascular aneurysm repair [EVAR]). An IR physician who performed
EVAR would be labeled as “other” because EVAR is considered a
procedure limited to VS physicians. It is likely that the most skilled IR
physicians with the highest volume of peripheral arterial procedures
are the ones who perform EVAR. In 2002, EVAR case volumes by
specialty were IR (4853), VS (10,859), and IC (1950).2 Not includ-
ing IR physicians who perform EVAR will underestimate the IR
market share and likely overestimate complications.
Fifth, IR treated sicker patients, as demonstrated by a much
higher rate of emergent and urgent procedures compared with VS
